Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis

Clinical and Experimental Immunology

Volumn 180, Issue 1, 2015, Pages 40-51

  Foureau, D M ^a   Walling, T L ^a   Maddukuri, V ^a   Anderson, W ^a   Culbreath, K ^a   Kleiner, D E ^c   Ahrens, W A ^a   Jacobs, C ^a   Watkins, P B ^b   Fontana, R J ^e   Chalasani, N ^f   Talwalkar, J ^g   Lee, W M ^h   Stolz, A ⁱ   Serrano, J ^d   Bonkovsky, H L ^j  

^a LEVINE CANCER INSTITUTE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f INDIANA UNIVERSITY   (United States)

^g MAYO CLINIC   (United States)

^h UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^j WAKE FOREST SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Autoimmunity; Drug induced liver injury; Inflammation; Viral hepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CD11B ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; IMMUNOGLOBULIN G; PARACETAMOL; SERUM GLOBULIN; LEUKOCYTE ANTIGEN;

ACUTE DRUG INDUCED LIVER INJURY; ACUTE HEPATITIS; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE LIVER DISEASE; B LYMPHOCYTE; BILIRUBIN BLOOD LEVEL; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EOSINOPHIL; EOSINOPHIL COUNT; EOSINOPHILIA; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HELPER CELL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; KUPFFER CELL; LEUKOCYTE; LIVER BIOPSY; LYMPHOCYTE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; NEUTROPHIL; PRIORITY JOURNAL; T LYMPHOCYTE; THROMBOCYTE COUNT; TOXIC HEPATITIS; VIRUS HEPATITIS; ACUTE DISEASE; ADOLESCENT; AGED; AUTOIMMUNE HEPATITIS; CD8+ T LYMPHOCYTE; CHILD; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; VERY ELDERLY;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; B-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; DRUG-INDUCED LIVER INJURY; FEMALE; HEPATITIS, AUTOIMMUNE; HEPATITIS, VIRAL, HUMAN; HUMANS; KILLER CELLS, NATURAL; KUPFFER CELLS; MALE; MIDDLE AGED;

EID: 84924303190     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12558     Document Type: Article

References (30)

1. Kelly DA. Acute liver failure. Indian J Pediatr 1999; 66:S104-109.
2. Wasley A, Grytdal S, Gallagher K. Surveillance for acute viral hepatitis - United States, 2006. MMWR Surveill Summ 2008; 57:1-24.
3. McFarlane IG, Heneghan MA. Autoimmunity and the female liver. Hepatol Res 2004; 28:171-176.
4. Washington MK. Autoimmune liver disease: overlap and outliers. Mod Pathol 2007; 20 (Suppl. 1):S15-30.
5. Bahjat KS, Prell RA, Allen HE etal. Activation of immature hepatic NK cells as immunotherapy for liver metastatic disease. J Immunol 2007; 179:7376-7384.
6. Doherty DG, O'Farrelly C. Innate and adaptive lymphoid cells in the human liver. Immunol Rev 2000; 174:5-20.
7. Jost S, Altfeld M. Control of human viral infections by natural killer cells. Annu Rev Immunol 2013; 31:163-194.
8. Kurachi K, Suzuki S, Sakaguchi T etal. Kupffer cells modulate splenic interleukin-10 production in endotoxin-induced liver injury after partial hepatectomy. J Hepatol 2003; 38:193-199.
9. Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ. Mechanisms of hepatotoxicity. Toxicol Sci 2002; 65:166-176.
10. Cheever AW, Williams ME, Wynn TA etal. Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. J Immunol 1994; 153:753-759.
11. Novobrantseva TI, Majeau GR, Amatucci A etal. Attenuated liver fibrosis in the absence of B cells. J Clin Invest 2005; 115:3072-3082.
12. Rockey DC, Seeff LB, Rochon J etal. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method. Hepatology 2010; 51:2117-2126.
13. deLemos AS, Foureau DM, Jacobs C, Ahrens W, Russo MW, Bonkovsky HL. Drug-induced liver injury with autoimmune features. Semin Liver Dis 2014; 34:194-204.
14. Bonkovsky HL, Shedlofsky SI, Jones DP, Russo M. Drug-induced liver injury. Chapter 25. In: Boyer TD, Manns MP, Sanyal A, eds. Zakim and Boyer's hepatology - a textbook of liver disease, 6th edn. Philadelphia: Saunders-Elsevier, 2012:417-461.
15. Chalasani N, Fontana RJ, Bonkovsky HL etal. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008; 135:1924-1934, 34 e1-4.
16. Fontana RJ, Watkins PB, Bonkovsky HL etal. Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct. Drug Saf 2009; 32:55-68.
17. Ishak K, Baptista A, Bianchi L etal. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22:696-699.
18. Kleiner DE, Chalasani NP, Lee WM etal. Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations. Hepatology 2014; 59:661-670.
19. Winwood PJ, Arthur MJ. Kupffer cells: their activation and role in animal models of liver injury and human liver disease. Semin Liver Dis 1993; 13:50-59.
20. Kelly BD, Heneghan MA, Bennani F, Connolly CE, O'Gorman TA. Nitrofurantoin-induced hepatotoxicity mediated by CD8+ T cells. Am J Gastroenterol 1998; 93:819-821.
21. Kleiner DE. The pathology of drug-induced liver injury. Semin Liver Dis 2009; 29:364-372.
22. Kaplowitz N. Drug-induced liver injury. Clin Infect Dis 2004; 38 (Suppl. 2):S44-48.
23. Vogel A, Manns MP, Strassburg CP. Autoimmunity and viruses. Clin Liver Dis 2002; 6:739-753.
24. Rubio CA. Detecting plasma cell precursors in autoimmune hepatitis. In Vivo 2012; 26:319-321.
25. Suzuki A, Brunt EM, Kleiner DE etal. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology 2011; 54:931-939.
26. Holt MP, Cheng L, Ju C. Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury. J Leukoc Biol 2008; 84:1410-1421.
27. Michael SL, Pumford NR, Mayeux PR, Niesman MR, Hinson JA. Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species. Hepatology 1999; 30:186-195.
28. Chitturi S, Farell GC. Adverse effects of hormones and hormone antagonists on the liver. In: Kaplowitz N, Deleve LD, eds. Drug-induced liver disease, 2nd edn. Amsterdam: Elsevier, 2007:702-722.
29. Navarro VJ, Barnhart H, Bonkovsky HL etal. Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology 2014; 60:1399-1408.
30. Fontana RJ, Seeff LB, Andrade RJ etal. Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop. Hepatology 2010; 52:730-742.